levetiracetam

Generic: levetiracetam

Labeler: taro pharmaceuticals u.s.a., inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler taro pharmaceuticals u.s.a., inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

levetiracetam 1000 mg/1

Manufacturer
Taro Pharmaceuticals U.S.A., Inc.

Identifiers & Regulatory

Product NDC 51672-4137
Product ID 51672-4137_559a39a2-ec8e-443b-9df0-4c909633981c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078960
Listing Expiration 2026-12-31
Marketing Start 2010-02-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516724137
Hyphenated Format 51672-4137

Supplemental Identifiers

RxCUI
311288 311289 311290 387003 403884
UPC
0351672414160
UNII
44YRR34555
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA078960 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1000 mg/1
source: ndc
Packaging
  • 60 TABLET, FILM COATED in 1 BOTTLE (51672-4137-4)
  • 30 TABLET, FILM COATED in 1 BOTTLE (51672-4137-6)
  • 750 TABLET, FILM COATED in 1 BOTTLE (51672-4137-8)
source: ndc

Packages (3)

Ingredients (1)

levetiracetam (1000 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "559a39a2-ec8e-443b-9df0-4c909633981c", "openfda": {"nui": ["N0000008486"], "upc": ["0351672414160"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003", "403884"], "spl_set_id": ["bf412e94-ca36-4da9-83d7-fb0f1323cf21"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (51672-4137-4)", "package_ndc": "51672-4137-4", "marketing_start_date": "20100201"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (51672-4137-6)", "package_ndc": "51672-4137-6", "marketing_start_date": "20100201"}, {"sample": false, "description": "750 TABLET, FILM COATED in 1 BOTTLE (51672-4137-8)", "package_ndc": "51672-4137-8", "marketing_start_date": "20100201"}], "brand_name": "Levetiracetam", "product_id": "51672-4137_559a39a2-ec8e-443b-9df0-4c909633981c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4137", "generic_name": "Levetiracetam", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "1000 mg/1"}], "application_number": "ANDA078960", "marketing_category": "ANDA", "marketing_start_date": "20100201", "listing_expiration_date": "20261231"}